WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007008479) TREATMENT OF PATIENTS WITH CANCER USING A CALICHEAMICIN-ANTIBODY CONJUGATE IN COMBINATION WITH ZOSUQUIDAR
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/008479    International Application No.:    PCT/US2006/025909
Publication Date: 18.01.2007 International Filing Date: 30.06.2006
IPC:
A61K 39/00 (2006.01)
Applicants: KANISA PHARMACEUTICALS, INC. [US/US]; 12264 El Camino Real, Suite 300, San Diego, California 92130 (US) (For All Designated States Except US).
SIKIC, Branimir [US/US]; (US) (For US Only).
HOTH, Daniel [US/US]; (US) (For US Only).
SOCKS, David [US/US]; (US) (For US Only).
GLENN, Scott [US/US]; (US) (For US Only).
MARCELLETTI, John [US/US]; (US) (For US Only).
WALSH, Michael, J. [US/US]; (US) (For US Only).
MULTANI, Pratik, S. [US/US]; (US) (For US Only)
Inventors: SIKIC, Branimir; (US).
HOTH, Daniel; (US).
SOCKS, David; (US).
GLENN, Scott; (US).
MARCELLETTI, John; (US).
WALSH, Michael, J.; (US).
MULTANI, Pratik, S.; (US)
Agent: HART, Daniel; Knobbe Martens Olson & Bear LLP, 2040 Main Street, 14th Floor, Irvine, California 92614 (US)
Priority Data:
60/696,756 06.07.2005 US
11/416,833 03.05.2006 US
11/416,992 03.05.2006 US
Title (EN) TREATMENT OF PATIENTS WITH CANCER USING A CALICHEAMICIN-ANTIBODY CONJUGATE IN COMBINATION WITH ZOSUQUIDAR
(FR) TRAITEMENT DE PATIENTS ATTEINTS DE CANCER A L'AIDE D'UN CONJUGUE DE CALICHEAMICINE ET D'ANTICORPS EN COMBINAISON AVEC DU ZOSUQUIDAR
Abstract: front page image
(EN)The present invention relates to a method of treating patients with solid tumors, leukemias, and other malignancies using a combination of zosuquidar and a calicheamicin-antibody conjugate, such as Mylotarg. The invention is also directed to pharmaceutical formulations comprising zosuquidar and calicheamicin-antibody conjugates. The formulations are particularly effective in treating relapsed Acute Myelogenous Leukemia (AML) and metastatic breast cancer.
(FR)La présente invention concerne une méthode de traitement de patients atteints de tumeurs solides, de leucémies, et autres tumeurs malignes à l'aide d'une combinaison de zosuquidar et d'un conjugué de calichéamicine et d'anticorps, tel que le Mylotarg. L'invention concerne également des compositions pharmaceutiques comprenant du zosuquidar et des conjugués de calichéamicine et d'anticorps. Lesdites préparations sont particulièrement efficaces pour le traitement de la leucémie myélogène aiguë (LMA) récidivante et le cancer du sein métastatique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)